• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于稳定期慢性阻塞性肺疾病的简单呼吸困难引导治疗算法与慢性阻塞性肺疾病全球倡议(GOLD)指南之间的一致性:一项试点研究。

Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: a pilot study.

作者信息

Cabrera Carlos, Casanova Ciro, Martín Yolanda, Mirabal Virginia, Sánchez María Del Carmen, Álvarez Felisa, Juliá Gabriel, Cabrera-Navarro Pedro, García-Bello Miguel Ángel, Marín José María, de-Torres Juan Pablo, Divo Miguel, Celli Bartolomé

机构信息

University Hospital of Gran Canaria Dr Negrín, Respiratory Service, Las Palmas de Gran Canaria, Spain.

University Hospital Nuestra Señora de la Candelaria, Respiratory Service, Santa Cruz de Tenerife, Spain.

出版信息

Int J Chron Obstruct Pulmon Dis. 2016 Jun 8;11:1217-22. doi: 10.2147/COPD.S100853. eCollection 2016.

DOI:10.2147/COPD.S100853
PMID:27354780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4907482/
Abstract

INTRODUCTION

Guidelines recommendations for the treatment of COPD are poorly followed. This could be related to the complexity of classification and treatment algorithms. The purpose of this study was to validate a simpler dyspnea-based treatment algorithm for inhaled pharmacotherapy in stable COPD, comparing its concordance with the current Global Initiative for Obstructive Lung Disease (GOLD) guideline.

METHODS

We enrolled patients who had been diagnosed with COPD in three primary care facilities and two tertiary hospitals in Spain. We determined anthropometric data, forced expiratory volume in the 1st second (percent), exacerbations, and dyspnea based on the modified Medical Research Council scale. We evaluated the new algorithm based on dyspnea and exacerbations and calculated the concordance with the current GOLD recommendations.

RESULTS

We enrolled 100 patients in primary care and 150 attending specialized care in a respiratory clinic. There were differences in the sample distribution between cohorts with 41% vs 26% in grade A, 16% vs 12% in grade B, 16% vs 22% in grade C, and 27% vs 40% in grade D for primary and respiratory care, respectively (P=0.005). The coincidence of the algorithm with the GOLD recommendations in primary care was 93% and 91.8% in the respiratory care cohort.

CONCLUSION

A simple dyspnea-based treatment algorithm for inhaled pharmacotherapy of COPD could be useful in the management of COPD patients and concurs very well with the recommended schema suggested by the GOLD initiative.

摘要

引言

慢性阻塞性肺疾病(COPD)治疗的指南建议执行情况不佳。这可能与分类和治疗算法的复杂性有关。本研究的目的是验证一种更简单的基于呼吸困难的稳定期COPD吸入药物治疗算法,并将其与当前的慢性阻塞性肺疾病全球倡议(GOLD)指南的一致性进行比较。

方法

我们纳入了西班牙三家初级保健机构和两家三级医院中被诊断为COPD的患者。我们根据改良的医学研究委员会量表确定人体测量数据、第1秒用力呼气量(百分比)、急性加重情况和呼吸困难情况。我们评估了基于呼吸困难和急性加重情况的新算法,并计算了其与当前GOLD建议的一致性。

结果

我们纳入了100名初级保健患者和150名在呼吸科门诊接受专科护理的患者。两个队列的样本分布存在差异,初级保健组和呼吸科护理组中,A级分别为41%对26%,B级分别为16%对12%,C级分别为16%对22%,D级分别为27%对40%(P = 0.005)。该算法与初级保健中GOLD建议的一致性为93%,在呼吸科护理队列中为91.8%。

结论

一种简单的基于呼吸困难情况的COPD吸入药物治疗算法可能有助于COPD患者的管理,并且与GOLD倡议建议的方案非常吻合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b30/4907482/295cf8def15c/copd-11-1217Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b30/4907482/679ff8a51e70/copd-11-1217Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b30/4907482/295cf8def15c/copd-11-1217Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b30/4907482/679ff8a51e70/copd-11-1217Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b30/4907482/295cf8def15c/copd-11-1217Fig2.jpg

相似文献

1
Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: a pilot study.一种用于稳定期慢性阻塞性肺疾病的简单呼吸困难引导治疗算法与慢性阻塞性肺疾病全球倡议(GOLD)指南之间的一致性:一项试点研究。
Int J Chron Obstruct Pulmon Dis. 2016 Jun 8;11:1217-22. doi: 10.2147/COPD.S100853. eCollection 2016.
2
Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.英国慢性阻塞性肺疾病的流行病学、严重程度及治疗(依据2013年慢性阻塞性肺疾病全球倡议)
Int J Chron Obstruct Pulmon Dis. 2015 May 13;10:925-37. doi: 10.2147/COPD.S82064. eCollection 2015.
3
Adherence to a COPD treatment guideline among patients in Hong Kong.香港 COPD 患者对治疗指南的遵从情况。
Int J Chron Obstruct Pulmon Dis. 2017 Nov 28;12:3371-3379. doi: 10.2147/COPD.S147070. eCollection 2017.
4
The effects of extrafine beclometasone/formoterol (BDP/F) on lung function, dyspnea, hyperinflation, and airway geometry in COPD patients: novel insight using functional respiratory imaging.超长效倍氯米松/福莫特罗(BDP/F)对慢性阻塞性肺疾病(COPD)患者肺功能、呼吸困难、肺过度充气及气道形态的影响:基于功能性呼吸成像的新见解
J Aerosol Med Pulm Drug Deliv. 2015 Apr;28(2):88-99. doi: 10.1089/jamp.2013.1064. Epub 2014 Jul 8.
5
2017 Global Initiative for Chronic Obstructive Lung Disease reclassifies half of COPD subjects to lower risk group.2017年慢性阻塞性肺疾病全球倡议将一半的慢性阻塞性肺疾病患者重新分类到低风险组。
Int J Chron Obstruct Pulmon Dis. 2018 Jan 3;13:165-173. doi: 10.2147/COPD.S151016. eCollection 2018.
6
Approaches to drug therapy for COPD in Russia: a proposed therapeutic algorithm.俄罗斯慢性阻塞性肺疾病(COPD)的药物治疗方法:一种建议的治疗算法
Int J Chron Obstruct Pulmon Dis. 2017 Apr 11;12:1125-1133. doi: 10.2147/COPD.S125594. eCollection 2017.
7
Determinants for changing the treatment of COPD: a regression analysis from a clinical audit.慢性阻塞性肺疾病(COPD)治疗改变的决定因素:一项临床审计的回归分析
Int J Chron Obstruct Pulmon Dis. 2016 Jun 2;11:1171-8. doi: 10.2147/COPD.S103614. eCollection 2016.
8
A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications.一项根据慢性阻塞性肺疾病全球倡议(GOLD)2014分类法对因接受常规治疗而就诊的慢性阻塞性肺疾病(COPD)患者当前的治疗情况和症状负担进行的横断面调查。
Int J Chron Obstruct Pulmon Dis. 2017 May 23;12:1527-1537. doi: 10.2147/COPD.S133793. eCollection 2017.
9
Categorization of COPD patients in Turkey via GOLD 2013 strategy document: ALPHABET study.通过《慢性阻塞性肺疾病全球倡议2013年策略文件》对土耳其慢性阻塞性肺疾病患者进行分类:字母表研究。
Int J Chron Obstruct Pulmon Dis. 2015 Nov 13;10:2485-94. doi: 10.2147/COPD.S87464. eCollection 2015.
10
Three-minute constant rate step test for detecting exertional dyspnea relief after bronchodilation in COPD.用于检测慢性阻塞性肺疾病(COPD)患者支气管扩张后运动性呼吸困难缓解情况的三分钟恒定速率阶梯试验
Int J Chron Obstruct Pulmon Dis. 2016 Nov 29;11:2991-3000. doi: 10.2147/COPD.S113113. eCollection 2016.

引用本文的文献

1
A Simplified Algorithm for the Diagnosis, Treatment, and Management of COPD in Routine Primary Care Practice.慢性阻塞性肺疾病在常规初级保健实践中的诊断、治疗和管理的简化算法。
Int J Chron Obstruct Pulmon Dis. 2020 Dec 16;15:3347-3355. doi: 10.2147/COPD.S281422. eCollection 2020.
2
Adherence of North-African Pulmonologists to the 2017-Global Initiative for Chronic Obstructive Lung Disease (GOLD) Pharmacological Treatment Guidelines (PTGs) of Stable Chronic Obstructive Pulmonary Disease (COPD).北非肺病专家对 2017 年全球慢性阻塞性肺疾病(COPD)倡议(GOLD)稳定期 COPD 药物治疗指南(PTGs)的依从性。
Biomed Res Int. 2020 Feb 28;2020:1031845. doi: 10.1155/2020/1031845. eCollection 2020.
3

本文引用的文献

1
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease.导致慢性阻塞性肺疾病的肺功能轨迹。
N Engl J Med. 2015 Jul 9;373(2):111-22. doi: 10.1056/NEJMoa1411532.
2
Inhaled steroids in COPD: when should they be used?慢性阻塞性肺疾病中的吸入性类固醇:何时应使用它们?
Lancet Respir Med. 2014 Nov;2(11):869-871. doi: 10.1016/S2213-2600(14)70227-9. Epub 2014 Nov 3.
3
Finding the best thresholds of FEV1 and dyspnea to predict 5-year survival in COPD patients: the COCOMICS study.寻找预测慢性阻塞性肺疾病(COPD)患者5年生存率的最佳第一秒用力呼气容积(FEV1)和呼吸困难阈值:COCOMICS研究
A Framework For Step Down Or Therapeutic Re-Organization For Withdrawal Of Inhaled Corticosteroids In Selected Patients With COPD: A Proposal For COPD Management.
COPD 管理中选定 COPD 患者停用吸入性皮质类固醇的阶梯式降阶或治疗性重新调整框架:一项 COPD 管理建议。
Int J Chron Obstruct Pulmon Dis. 2019 Sep 23;14:2185-2193. doi: 10.2147/COPD.S216059. eCollection 2019.
4
Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICS.吸入性慢性阻塞性肺病治疗与已发表策略的一致性。SPIROMICS 中对全球慢性阻塞性肺病倡议建议的分析。
Ann Am Thorac Soc. 2019 Feb;16(2):200-208. doi: 10.1513/AnnalsATS.201804-283OC.
5
A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease.关于在慢性阻塞性肺疾病的临床实践中撤回吸入性皮质类固醇的建议。
Respir Res. 2017 Nov 28;18(1):198. doi: 10.1186/s12931-017-0682-y.
6
Adherence to COPD management guidelines in general practice? A review of the literature.全科医疗中对慢性阻塞性肺疾病管理指南的依从性?文献综述
Ir J Med Sci. 2018 May;187(2):403-407. doi: 10.1007/s11845-017-1651-7. Epub 2017 Jul 22.
7
Persistent disabling breathlessness in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中持续存在的致残性呼吸困难。
Int J Chron Obstruct Pulmon Dis. 2016 Nov 9;11:2805-2812. doi: 10.2147/COPD.S119992. eCollection 2016.
PLoS One. 2014 Feb 27;9(2):e89866. doi: 10.1371/journal.pone.0089866. eCollection 2014.
4
Prevalence of chronic obstructive pulmonary disease in the Canary Islands.加那利群岛慢性阻塞性肺疾病的患病率。
Arch Bronconeumol. 2014 Jul;50(7):272-7. doi: 10.1016/j.arbres.2013.12.006. Epub 2014 Feb 4.
5
Longitudinal assessment in COPD patients: multidimensional variability and outcomes.COPD 患者的纵向评估:多维变异性和结局。
Eur Respir J. 2014 Mar;43(3):745-53. doi: 10.1183/09031936.00096913. Epub 2013 Sep 26.
6
Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting.慢性阻塞性肺疾病相关成本与指南依从性:初级保健环境中的一项研究。
Ther Adv Respir Dis. 2013 Jun;7(3):139-50. doi: 10.1177/1753465813484080. Epub 2013 May 7.
7
The evaluation of general practitioners' awareness/knowledge and adherence to the GOLD guidelines in a Shanghai suburb.上海某郊区全科医生对慢性阻塞性肺疾病全球倡议(GOLD)指南的知晓/认知及遵循情况评估
Asia Pac J Public Health. 2015 Mar;27(2):NP2067-78. doi: 10.1177/1010539513475654. Epub 2013 Feb 17.
8
Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population.采用新 GOLD 分类法预测慢性阻塞性肺疾病的临床病程:一项普通人群研究。
Am J Respir Crit Care Med. 2012 Nov 15;186(10):975-81. doi: 10.1164/rccm.201207-1299OC. Epub 2012 Sep 20.
9
Barriers to adherence to COPD guidelines among primary care providers.基层医疗服务提供者遵循 COPD 指南的障碍。
Respir Med. 2012 Mar;106(3):374-81. doi: 10.1016/j.rmed.2011.09.010. Epub 2011 Oct 13.
10
The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.慢性阻塞性肺疾病的进展是异质的:BODE 队列的经验。
Am J Respir Crit Care Med. 2011 Nov 1;184(9):1015-21. doi: 10.1164/rccm.201105-0831OC.